Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

GYRE

GYRE THERAPEUTICS, INC.

CIK 0001124105 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$6.86
↑ 0.00 (0.00%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap
$665.61M
P/E Ratio
-179.31
EPS
0.06
Dividend Yield
Not covered
52W Position
36%
Beta
1.34

Valuation multiples

Fwd P/E
78.12
PEG
Not covered
P/B
4.86
P/S
5.69
EV/Revenue
5.37
ROE
-2.7%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 36%
$5.44$9.42

Latest Financials

2025-12-31 FY
Revenue
$116.59M
Net Income
$9.88M
Total Assets
$166.13M
Free Cash Flow
-$180.00K

Recent news